Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
CX-5461 was administered orally at 50 mg/kg either once daily or every 3 days
A combination of YM-155
K858 induces mitotic arrest and growth inhibition via the activation of the Mad2-mediated spindle checkpoint
BAY11-7082
is a potent and selective inhibitor of class IIa histone deacetylases (HDACs)
TAK-875 (Fasiglifam) - GPR40 Agonist. CAS# 1374598-80-7 0083 CX-5461 was administered orally atTAK 875 (Fasiglifam), CAS No. 1374598 80 7, is the potent, selective and orally bioavailable partial GPR40 agonist with an EC50 ~14 nM. It has binding affinity to the human GPR40 receptor with Ki of 38 nM and the rat GPR40 receptor with Ki of 140 nM. TAK 875 has no agonist potency to other members of the FFA receptor family with EC50 >10 M. The 2. 3 resolution co complex structure of hGPR40 TAK 875 reveals a unique binding mode of TAK 875 and suggests
US$ 22.00
US$ 82.00
US$ 79.00
US$ 177.50